✦ LIBER ✦

Clinical experience of hormone therapy to bone metastatic prostate cancer

✍ Scribed by MASAMI WAKISAKA; KAZUSHI NOMURA

Book ID: 108977053
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 83 KB
Volume: 13
Category: Article
ISSN: 0919-8172
DOI: 10.1111/j.1442-2042.2006.01345.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical trials in metastatic hormone-re

Clinical trials in metastatic hormone-refractory prostate cancer: Improving docetaxel therapy by targeting bone-related growth factors

✍ Daniel P. Petrylak 📂 Article 📅 2007 🏛 Current Science Inc. 🌐 English ⚖ 103 KB

Clinical benefit of bone-targeted radiom

Clinical benefit of bone-targeted radiometabolic therapy with153Sm-EDTMP combined with chemotherapy in patients with metastatic hormone-refractory prostate cancer

✍ Sergio Ricci; Giuseppe Boni; Ilaria Pastina; Dario Genovesi; Claudia Cianci; Ser 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 160 KB

Estimating Clinically Meaningful Changes

Estimating Clinically Meaningful Changes for the Functional Assessment of Cancer Therapy—Prostate: Results from a Clinical Trial of Patients with Metastatic Hormone-Refractory Prostate Cancer

✍ David Cella; Michael B. Nichol; David Eton; Joel B. Nelson; Parvez Mulani 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

Emergence of metastatic hormone-refracto

Emergence of metastatic hormone-refractory disease in prostate cancer after anti-androgen therapy

✍ Edmund Chun Yu Lee; Martin P.R. Tenniswood 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 258 KB

## Abstract The anti‐androgens used in prostate cancer therapy have been designed to interfere with the normal androgen receptor (AR)‐mediated processes that ensure prostate cell survival, triggering tumor cells to undergo programmed cell death. While anti‐androgens were originally designed to trea

Metastatic prostate carcinoma to bone :

Metastatic prostate carcinoma to bone : Clinical and pathologic features associated with cancer-specific survival

✍ John C. Cheville; Donald Tindall; Christopher Boelter; Robert Jenkins; Christine 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 662 KB

## Background: The objective of this study was to examine the clinical and pathologic features of metastatic prostate carcinoma to bone in a large cohort of men, and the associations of these features with outcome. ## Methods: Sixty-eight men who underwent surgery for metastatic prostate carcinom

Immunohistochemical study of androgen re

Immunohistochemical study of androgen receptors in metastatic prostate cancer. Comparison of receptor content and response to hormonal therapy

✍ Marcus V. Sadi; Patrick C. Walsh; Evelyn R. Barrack 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 867 KB

A longstanding goal has been to determine whether androgen receptor (AR) levels could be used to predict the clinical response of metastatic prostate cancer to androgen withdrawal therapy. A major limitation of previous studies was the use of homogenized tissue, which yields an average AR content fo